Herbas VPB

Print
EN | LT
LT - METHOD FOR SELECTING CHEMOTHERAPY FOR GASTRIC CANCER PATIENT USING COMBINATION DRUG OF TEGAFUR, GIMERACIL AND OTERACIL POTASSIUM AND EGFR INHIBITOR
EN - METHOD FOR SELECTING CHEMOTHERAPY FOR GASTRIC CANCER PATIENT USING COMBINATION DRUG OF TEGAFUR, GIMERACIL AND OTERACIL POTASSIUM AND EGFR INHIBITOR

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. G01N 33/53
A61K 31/4412
A61K 31/513
A61K 31/53
A61K 39/395
A61K 45/00
A61P 1/16
A61P 35/00
A61P 43/00
C12Q 1/68
G01N 33/48
C12N 15/09
European patent
(11) Number of the document 2711704
(13) Kind of document T
(96) European patent application number 12785253.1
Date of filing the European patent application 2012-05-15
(97) Date of publication of the European application 2014-03-26
(45) Date of publication and mention of the grant of the patent 2017-06-28
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/JP2012/062423
Date 2012-05-15
PCT application publication
(87) Number WO 2012/157647
Date 2012-11-22
Priority applications
(30) Number Date Country code
2011109599 2011-05-16 JP
Inventors
(72)
KOBUNAI, Takashi, JP
SAITO, Hitoshi, JP
TAKECHI, Teiji, JP
Grantee
(73) Taiho Pharmaceutical Co., Ltd., 1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444, JP
Title
(54) METHOD FOR SELECTING CHEMOTHERAPY FOR GASTRIC CANCER PATIENT USING COMBINATION DRUG OF TEGAFUR, GIMERACIL AND OTERACIL POTASSIUM AND EGFR INHIBITOR
  METHOD FOR SELECTING CHEMOTHERAPY FOR GASTRIC CANCER PATIENT USING COMBINATION DRUG OF TEGAFUR, GIMERACIL AND OTERACIL POTASSIUM AND EGFR INHIBITOR